Dosing: Relapsed or Refractory CD19-positive B-cell Precursor ALL
Administration: Relapsed or Refractory CD19-positive B-cell Precursor ALL
Dose Preparation: Relapsed or Refractory CD19-positive B-cell Precursor ALL
Efficacy (Adults): Relapsed or Refractory CD19-positive B-cell Precursor ALL
Efficacy (Adults Ph+): Relapsed or Refractory CD19-positive B-cell Precursor ALL
Efficacy (Pediatric): Relapsed or Refractory CD19-positive B-cell Precursor ALL
Safety Profile (Adults): Relapsed or Refractory CD19-positive B-cell Precursor ALL
Safety Profile (Adults Ph+): Relapsed or Refractory CD19-positive B-cell Precursor ALL
Safety Profile (Pediatrics): Relapsed or Refractory CD19-positive B-cell Precursor ALL
Dosing: Minimal Residual Disease (+) ALL
Administration: Minimal Residual Disease (+) ALL
Dose Preparation: Minimal Residual Disease (+) ALL
Efficacy: Minimal Residual Disease (+) ALL
Safety Profile: Minimal Residual Disease (+) ALL
drug label
Blincyto prescribing information
Have more Blincyto questions?
Submit MSL Request
Learn More
Your request will be referred to the appropriate Amgen Inc medical professional, such as a Blincyto pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report a Blincyto issue?
ONLINE FORMReport adverse event
Learn More
You can report a Blincyto adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
prior authorization
Blincyto Prior authorization resources
Complete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
Coverage Authorization Appeals
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
Benefits Verification
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
Receive Assistance from an FRM Regarding Reimbursement Information
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Blincyto Financial assistance options
Co-pay savings program
commercial only
Enroll in Patient Savings Program
Learn More
Overview
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Learn More
Overview
Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
100% free (outside of insurance)
Patient eligibility
HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
Amgen Safety Net Foundation Patient Assistance Program
Learn More
Overview
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Blincyto Patient education
Getting started on Blincyto
NOT PROVIDED BY BRANDInstructions For Use: Relapsed or Refractory CD19-positive B-cell Precursor ALL
NOT PROVIDED BY BRANDInstructions For Use: Minimal Residual Disease (+) ALL
Patient toolkit
About Blincyto: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Blincyto (Pediatrics): Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Receiving Blincyto: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Blincyto: Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Blincyto (Pediatrics): Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Receiving Treatment: Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources: Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Brochure : Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Brochure: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Pediatric Patient Brochure: Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Pediatric Patient Brochure: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Medication Information Card: Minimal Residual Disease (+) ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Medical Information Card: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL - Spanish
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Pediatric Patient Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Pediatric Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL - Spanish
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Medical Information Card: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
people also ask
Blincyto FAQs
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available